Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01337362
Other study ID # H-1-2011-024
Secondary ID
Status Completed
Phase N/A
First received March 30, 2011
Last updated October 15, 2014
Start date May 2011
Est. completion date June 2013

Study information

Verified date October 2014
Source Hillerod Hospital, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: The Regional Committee on Biomedical Research EthicsDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

Patients with type 1 diabetes are at risk of very low blood sugar levels (hypoglycaemia) as a severe side effect to insulin therapy, in particular subjects who have lost warning of hypoglycaemia. During hypoglycaemia a low frequent activity can be seen with electroencephalography (EEG) as cognitive function declines.

The purpose of the study is to investigate the activity in the brain, the cognitive function, and the skin temperature when patients are exposed to repeated hypoglycaemia. The results will show whether the response to hypoglycaemia will change after repeated episodes.

It is our hope that results can contribute to improved understanding of hypoglycaemic EEG changes.


Description:

Background:

Patients with type 1 diabetes are at risk of severe hypoglycaemia as a severe side effect to insulin therapy, in particular subjects who have lost warning of hypoglycaemia (hypoglycaemia unawareness). The episodes are associated with impaired quality of life and can lead to permanent brain damage and death.

During hypoglycaemia a low frequent activity can be seen with electroencephalography (EEG) as cognitive function declines. Repeated hypoglycaemic episodes result in down regulation of counter regulatory and symptomatic responses. It is not known whether a similar phenomenon is present for cerebral dysfunction as judged by EEG changes and cognitive function.

The purpose is to investigate the activity in the brain, the cognitive function, and the skin temperature when patients are exposed to repeated hypoglycaemia. The results will show whether the response to hypoglycaemia will change after repeated episodes.

The methods:

The investigators will recruit two groups of patients: Patients with hypoglycemia awareness and patients with hypoglycaemic unawareness.

The patients are exposed to hypoglycaemia on two concomitant days while the investigators record EEG and perform cognitive tests. Skin temperature is assessed by the use of thermography. If the patient has hypoglycaemic unawareness a 4 week period follows where the glycaemic control is loosened to avoid hypoglycaemia episodes and the patients is then exposed to hypoglycaemia again.

The prospect:

It is the investigators hope that results can contribute to improved understanding of hypoglycaemic EEG changes and skin temperature changes. This could be of potential benefit for patients with hypoglycaemic unawareness.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Type 1 diabetes

- Age > 18 years

- - Have had diabetes for more than 5 years

- Negative pregnancy test

- Caucasian

- Signed written informed consent

Exclusion Criteria:

- Pregnant or breastfeeding

- Epilepsy

- Self-perceived impaired hearing

- Use of antiepileptic medicine

- Use of neuroleptics within the last 6 months

- Use of benzodiazepines within the last month

- Use of betablockers

- Previous stroke or other disease in the brain

- Cardiovascular disease

- Alcohol-, drug- or medicine abuse

- Previous allergic reaction to heparin

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Insulin clamp
Patients will be exposed to low bloodsugar

Locations

Country Name City State
Denmark Hillerod Hospital Hillerød

Sponsors (4)

Lead Sponsor Collaborator
Hillerod Hospital, Denmark Hypo-Safe A/S, Rigshospitalet, Denmark, University of Southern Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary EEG EEG will be analysed in order to see whether there are any differences between aware and unaware patients during hypoglycaemia. It is our hope that the result can help develop an alarm before the patient experiences severe hypoglycaemia. 2 years No
Secondary QTc interval The investigators want to investigate whether the QTc complex gets wider during hypoglycaemia. This is in order to see whether long QTc could be the explanation behind sudden dearth in diabetes patients. 2 years Yes
Secondary Skin temperature Skin temperature will be measured by thermography. The investigators want to see whether the skin can be used as a biomarker for hypoglycaemia. 2 years No
Secondary Auditory evoked potentials The investigators what to see whether there is any difference in auditory evoked potentials (AEP) between aware and unaware diabetic patients. The subject will hear a common and a rare sound in a 4:1 ratio while the EEG is recorded. Afterwards the data is analyzed and the AEPs are addressed. 2 years No
Secondary Cognitive function The investigators want to address whether there are any differences in the cognitive function between aware and unaware patients. The cognitive function will be addressed by the use of cognitive function tests (CalCAP) and Stroops tests as well. 2 years No
See also
  Status Clinical Trial Phase
Completed NCT01922817 - DPP4inhibitors in Type 1 Diabetes Phase 3
Completed NCT02107326 - Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes N/A
Completed NCT02341313 - Point of Care Ketone Measurement in the Newborn
Completed NCT01347801 - Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1 N/A
Completed NCT05470842 - How Common is Hypoglycaemia in Older People With Diabetes Who Fall? N/A
Completed NCT02778269 - Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study N/A
Active, not recruiting NCT02241317 - Diabetes Mellitus at the University Medical Center of Mannheim N/A
Completed NCT02057848 - Carbohydrates to Prevent Hypoglycaemia During Physical Activity in Patients With Type 1 Diabetes N/A
Terminated NCT02836353 - Metabolic Consequences of Gastrointestinal Surgery N/A
Completed NCT01526044 - Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients N/A
Completed NCT02347553 - Effect of Hypoglycaemia on Social Cognition and Cardiac Conduction N/A